Rare diseases
Investigational molecules
Locations
Back to Portugal679 clinical trials in Senhora Da Hora, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on How Larotrectinib Works in Adults with Solid Tumors with NTRK Gene Fusion
PortugalStudy Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy
PortugalStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
PortugalStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
PortugalStudy on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment
PortugalStudy on Sibeprenlimab for Patients with IgA Nephropathy
PortugalStudy of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer
PortugalStudy on Trehalose Dihydrate for Treating Spinocerebellar Ataxia in Adults
PortugalStudy of Pembrolizumab for Patients with Advanced Solid Tumors
PortugalStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
PortugalStudy on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension
PortugalStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Alzheimer's disease and associated conditions, including studies on psychosis treatment and cognitive decline prevention. Multiple trials exploring migraine prevention with novel therapeutic approaches.
Studies are evaluating both symptomatic relief and disease modification strategies.
Comprehensive research in breast cancer treatments, particularly focusing on HR+/HER2- variants and innovative combination therapies. Advanced studies in non-small cell lung cancer exploring new treatment paradigms.
Trials emphasize targeted therapies and immunotherapy approaches.
Groundbreaking research in severe asthma management and chronic rhinosinusitis. Studies evaluating new treatments for COPD with focus on long-term safety and efficacy.
Emphasis on innovative inhaler combinations and targeted biological treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
